ARCHIVES

ICF Clement Joins Dynalectron In FCRF

This article is from The Cancer Letter archive.

Vol. 13 No. 02 | January 9, 1987

Download PDF Visit The Full Archive

Related Articles

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

June 25, 2010

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown

October 1, 2010

Final Issue Of 1992

December 11, 1992

NTP Board Okays Contract Concepts

July 10, 1981

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985